Add to ORKGObjective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin and observe any association with increased risk of excessive coagulation activation, morbidity, or mortality
Inflammation and coagulation occur concomitantly in sepsis. Thrombin activates platelet that leads t...
The tissue factor (TF)/factor (F)VIIa complex is the primary initiator of coagulation in vivo. Tissu...
Tissue factor pathway inhibitor (TFPI) is a multivalent, Kunitz-type plasma proteinase inhibitor tha...
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin...
Objective Tissue factor pathway inhibitor (TFPI) is a potent anticoagulant protein in the extrinsic ...
Background-Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of the extrinsic coagu...
Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of the extrinsic coagulation path...
Tissue factor pathway inhibitor (TFPI) is the main inhibitor of tissue factor (TF)-mediated coagulat...
See also Ariëns RAS. The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has...
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type inhibitor that regulates the initiation of t...
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type inhibitor that regulates the initiation of t...
AIM: In patients with atherosclerosis there is an activation of the tissue factor mediated coagulat...
Tissue factor pathway inhibitor (TFPI) is a recently 'rediscovered' inhibitor of tissue factor media...
Background—This study was designed to evaluate the plasma levels of tissue factor (TF) and tissue fa...
Heparin, a negatively charged sulphated glycosaminoglycan, is clinically the most important antithro...
Inflammation and coagulation occur concomitantly in sepsis. Thrombin activates platelet that leads t...
The tissue factor (TF)/factor (F)VIIa complex is the primary initiator of coagulation in vivo. Tissu...
Tissue factor pathway inhibitor (TFPI) is a multivalent, Kunitz-type plasma proteinase inhibitor tha...
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin...
Objective Tissue factor pathway inhibitor (TFPI) is a potent anticoagulant protein in the extrinsic ...
Background-Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of the extrinsic coagu...
Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of the extrinsic coagulation path...
Tissue factor pathway inhibitor (TFPI) is the main inhibitor of tissue factor (TF)-mediated coagulat...
See also Ariëns RAS. The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has...
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type inhibitor that regulates the initiation of t...
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type inhibitor that regulates the initiation of t...
AIM: In patients with atherosclerosis there is an activation of the tissue factor mediated coagulat...
Tissue factor pathway inhibitor (TFPI) is a recently 'rediscovered' inhibitor of tissue factor media...
Background—This study was designed to evaluate the plasma levels of tissue factor (TF) and tissue fa...
Heparin, a negatively charged sulphated glycosaminoglycan, is clinically the most important antithro...
Inflammation and coagulation occur concomitantly in sepsis. Thrombin activates platelet that leads t...
The tissue factor (TF)/factor (F)VIIa complex is the primary initiator of coagulation in vivo. Tissu...
Tissue factor pathway inhibitor (TFPI) is a multivalent, Kunitz-type plasma proteinase inhibitor tha...